Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice
about
Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of TuberculosisTissue-Resident T Cells as the Central Paradigm of Chlamydia ImmunityChlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidatesConsiderations for the rational design of a Chlamydia vaccineChlamydial protease-like activity factor mediated protection against C. trachomatis in guinea pigsImmunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearanceChlamydia trachomatis control requires a vaccine.Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice.Liposomes as vaccine delivery systems: a review of the recent advances.Use of a Guinea pig-specific transcriptome array for evaluation of protective immunity against genital chlamydial infection following intranasal vaccination in Guinea pigs.Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.A re-evaluation of the role of B cells in protective immunity to Chlamydia infectionBioinformatic Analysis of Chlamydia trachomatis Polymorphic Membrane Proteins PmpE, PmpF, PmpG and PmpH as Potential Vaccine Antigens.Frequency of Chlamydia trachomatis-specific T cell interferon-γ and interleukin-17 responses in CD4-enriched peripheral blood mononuclear cells of sexually active adolescent females.Comparison of Murine Cervicovaginal Infection by Chlamydial Strains: Identification of Extrusions Shed In vivoGenital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.A Protective Vaccine against Chlamydia Genital Infection Using Vault Nanoparticles without an Added Adjuvant.Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.Update on Chlamydia trachomatis Vaccinology.Using MHC Molecules to Define a Chlamydia T Cell Vaccine.Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.An atypical CD8 T-cell response to Chlamydia muridarum genital tract infections includes T cells that produce interleukin-13.Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status.A Chlamydia-Specific TCR-Transgenic Mouse Demonstrates Th1 Polyfunctionality with Enhanced Effector Function.Perspective: my 37 year journey through Chlamydia research: Chlamydia antigen analysis using monoclonal antibodies and major histocompatibility complex molecules.B cell presentation of Chlamydia antigen selects out protective CD4γ13 T cells; implications for genital tract tissue resident memory lymphocyte clusters.Chlamydia abortus Pmp18.1 Induces IL-1β Secretion by TLR4 Activation through the MyD88, NF-κB, and Caspase-1 Signaling Pathways.The M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune
P2860
Q27327288-B6F392C5-D33D-4183-BC79-553DC06C6353Q28075820-F392A8C6-B5D8-4E33-AB42-50C52FC67157Q28083729-DFA032F6-71ED-45EB-B937-160FD92F06BBQ33601324-D2A89E13-0D86-4FD8-AA7F-9422C14E11E6Q33740057-07854DCB-2D26-41F7-A1E6-1A1D585F67EFQ33757880-C9FBB8C4-3A77-4AC1-A45F-027AEA2D9EB5Q34103774-A5ED2BB6-D4D8-43D9-A3B9-F0CD48329061Q34103785-74E1F54C-C4AE-417A-A6C8-C0C36598D3CBQ34418761-7DEAF37D-7BEE-4901-838A-57229B37EE65Q34680475-D52A1B3D-F62E-4433-A9D0-B327629FA61DQ35329559-67C64D82-492D-4B5E-A219-637ACD063D08Q35471373-F5F34F4C-30CB-4DBA-A3A9-731B59D98593Q35679647-3811901B-6152-4F63-BC83-E5D41A628550Q35861640-A883A6B5-877F-4E1C-9637-0C4B1C47F4BDQ37622035-9D0E2BE3-C561-412A-A2F7-1EAFE206C9BCQ37712799-5CEB6F90-5C4E-4D58-B731-721FAF4D2460Q37727719-E2D7A476-9086-47C6-8E7D-D1B052F2679BQ37834482-73DBBBEF-4881-4442-8CBD-5B949489D88CQ37834874-792A53AA-D6F2-4B9E-B29C-F420D7677B16Q37836771-5D03393A-E10F-413D-8309-7753A2DE0CB5Q37837221-A3357653-A302-485C-9EF2-D265C0E949ACQ37845143-54DD289D-0A16-49AC-B64D-18BDE2593468Q38028994-EFFD2CBE-D4F3-46B5-8864-09F7907838EFQ40074057-BEF17898-98A5-441F-9855-F3F100BBD571Q44058913-73C31A48-2279-482C-B0A4-F5EB65C627E1Q44059377-8D97A9B8-FE2C-4829-972A-540AD2141875Q47352451-C00B2580-60C2-43C9-B95E-43C63A13DD08Q58122056-9561D87B-CB7F-4173-86AD-039A748E468D
P2860
Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice
@ast
Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice
@en
type
label
Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice
@ast
Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice
@en
prefLabel
Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice
@ast
Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice
@en
P2093
P2860
P356
P1476
Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice
@en
P2093
Caixia Shen
Karuna P Karunakaran
Robert C Brunham
Xiaozhou Jiang
P2860
P304
P356
10.1128/IAI.06338-11
P407
P577
2012-01-30T00:00:00Z